HCPCS code J7311 — Inj., retisert, 0.01 mg.
Status: Active.
Effective Oct 1, 2019.
Source: CMS HCPCS Level II.
J7311
ActiveInj., retisert, 0.01 mg
Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Oct 1, 2019
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
9225
MUE — Medically Unlikely Edits
Maximum units of J7311 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 118 |
| Practitioner Services | 118 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 24208-0416-01 | Retisert |